 | • レポートコード：MRC2-11QY14074 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポリペプチド薬のグローバル市場について調査・分析したレポートです。種類別（注射、経鼻、肺投与、経口投与、経皮投与）市場規模、用途別（免疫調節薬（アレルギー感染症・免疫）、消化器系薬（胃腸型）、骨・結合組織型（甲状腺ホルモン薬）、婦人科/産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン・その他血糖降下薬））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポリペプチド薬の競争状況、市場シェア ・世界のポリペプチド薬市場：種類別市場規模 2015年-2020年（注射、経鼻、肺投与、経口投与、経皮投与） ・世界のポリペプチド薬市場：種類別市場規模予測 2021年-2026年（注射、経鼻、肺投与、経口投与、経皮投与） ・世界のポリペプチド薬市場：用途別市場規模 2015年-2020年（免疫調節薬（アレルギー感染症・免疫）、消化器系薬（胃腸型）、骨・結合組織型（甲状腺ホルモン薬）、婦人科/産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン・その他血糖降下薬）） ・世界のポリペプチド薬市場：用途別市場規模予測 2021年-2026年（免疫調節薬（アレルギー感染症・免疫）、消化器系薬（胃腸型）、骨・結合組織型（甲状腺ホルモン薬）、婦人科/産科薬、腫瘍薬、泌尿器系薬、代謝薬（インスリン・その他血糖降下薬）） ・北米のポリペプチド薬市場分析：米国、カナダ ・ヨーロッパのポリペプチド薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポリペプチド薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポリペプチド薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポリペプチド薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Merck Serono、Ferring Pharmaceuticals、Ipsen PHarma Biotech、Lilly、Asahi Kasei、AstraZeneca、SciClone Pharmaceuticals、Takeda、Roche、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Polypeptide antibiotic. Polypeptide antibiotics are a chemically diverse class of anti-infective and antitumor antibiotics containing non-protein polypeptide chains. Examples of this class include actinomycin, bacitracin, colistin, and polymyxin B. Actinomycin-D has found use in cancer chemotherapy.
Market Analysis and Insights: Global Polypeptide Drug Market
The global Polypeptide Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Polypeptide Drug Scope and Market Size
Polypeptide Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polypeptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Polypeptide Drug market is segmented into
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration
Segment by Application, the Polypeptide Drug market is segmented into
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Regional and Country-level Analysis
The Polypeptide Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Polypeptide Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Polypeptide Drug Market Share Analysis
Polypeptide Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polypeptide Drug business, the date to enter into the Polypeptide Drug market, Polypeptide Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Roche
Sanofi
1 Study Coverage
1.1 Polypeptide Drug Product Introduction
1.2 Market Segments
1.3 Key Polypeptide Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Polypeptide Drug Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Nasal Administration
1.4.4 Lung Administration
1.4.5 Oral Administration
1.4.6 Transdermal Administration
1.5 Market by Application
1.5.1 Global Polypeptide Drug Market Size Growth Rate by Application
1.5.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.5.3 Digestive System Drugs (Gastrointestinal Type)
1.5.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.5.5 Gynecologic or Obstetric Drug
1.5.6 Tumor Drug
1.5.7 Urinary System Drug
1.5.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Polypeptide Drug Market Size, Estimates and Forecasts
2.1.1 Global Polypeptide Drug Revenue 2015-2026
2.1.2 Global Polypeptide Drug Sales 2015-2026
2.2 Global Polypeptide Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Polypeptide Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Polypeptide Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Polypeptide Drug Competitor Landscape by Players
3.1 Polypeptide Drug Sales by Manufacturers
3.1.1 Polypeptide Drug Sales by Manufacturers (2015-2020)
3.1.2 Polypeptide Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Polypeptide Drug Revenue by Manufacturers
3.2.1 Polypeptide Drug Revenue by Manufacturers (2015-2020)
3.2.2 Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Polypeptide Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Polypeptide Drug Revenue in 2019
3.2.5 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Polypeptide Drug Price by Manufacturers
3.4 Polypeptide Drug Manufacturing Base Distribution, Product Types
3.4.1 Polypeptide Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Polypeptide Drug Product Type
3.4.3 Date of International Manufacturers Enter into Polypeptide Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Polypeptide Drug Market Size by Type (2015-2020)
4.1.1 Global Polypeptide Drug Sales by Type (2015-2020)
4.1.2 Global Polypeptide Drug Revenue by Type (2015-2020)
4.1.3 Polypeptide Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Polypeptide Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Polypeptide Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Polypeptide Drug Revenue Forecast by Type (2021-2026)
4.2.3 Polypeptide Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Polypeptide Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Polypeptide Drug Market Size by Application (2015-2020)
5.1.1 Global Polypeptide Drug Sales by Application (2015-2020)
5.1.2 Global Polypeptide Drug Revenue by Application (2015-2020)
5.1.3 Polypeptide Drug Price by Application (2015-2020)
5.2 Polypeptide Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Polypeptide Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Polypeptide Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Polypeptide Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Polypeptide Drug by Country
6.1.1 North America Polypeptide Drug Sales by Country
6.1.2 North America Polypeptide Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Polypeptide Drug Market Facts & Figures by Type
6.3 North America Polypeptide Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Polypeptide Drug by Country
7.1.1 Europe Polypeptide Drug Sales by Country
7.1.2 Europe Polypeptide Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Polypeptide Drug Market Facts & Figures by Type
7.3 Europe Polypeptide Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Polypeptide Drug by Region
8.1.1 Asia Pacific Polypeptide Drug Sales by Region
8.1.2 Asia Pacific Polypeptide Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Polypeptide Drug Market Facts & Figures by Type
8.3 Asia Pacific Polypeptide Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Polypeptide Drug by Country
9.1.1 Latin America Polypeptide Drug Sales by Country
9.1.2 Latin America Polypeptide Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Polypeptide Drug Market Facts & Figures by Type
9.3 Central & South America Polypeptide Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Polypeptide Drug by Country
10.1.1 Middle East and Africa Polypeptide Drug Sales by Country
10.1.2 Middle East and Africa Polypeptide Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Polypeptide Drug Market Facts & Figures by Type
10.3 Middle East and Africa Polypeptide Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Polypeptide Drug Products Offered
11.1.5 Novartis Related Developments
11.2 Merck Serono
11.2.1 Merck Serono Corporation Information
11.2.2 Merck Serono Description and Business Overview
11.2.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Serono Polypeptide Drug Products Offered
11.2.5 Merck Serono Related Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Corporation Information
11.3.2 Ferring Pharmaceuticals Description and Business Overview
11.3.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ferring Pharmaceuticals Polypeptide Drug Products Offered
11.3.5 Ferring Pharmaceuticals Related Developments
11.4 Ipsen PHarma Biotech
11.4.1 Ipsen PHarma Biotech Corporation Information
11.4.2 Ipsen PHarma Biotech Description and Business Overview
11.4.3 Ipsen PHarma Biotech Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipsen PHarma Biotech Polypeptide Drug Products Offered
11.4.5 Ipsen PHarma Biotech Related Developments
11.5 Lilly
11.5.1 Lilly Corporation Information
11.5.2 Lilly Description and Business Overview
11.5.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lilly Polypeptide Drug Products Offered
11.5.5 Lilly Related Developments
11.6 Asahi Kasei
11.6.1 Asahi Kasei Corporation Information
11.6.2 Asahi Kasei Description and Business Overview
11.6.3 Asahi Kasei Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Asahi Kasei Polypeptide Drug Products Offered
11.6.5 Asahi Kasei Related Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Description and Business Overview
11.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AstraZeneca Polypeptide Drug Products Offered
11.7.5 AstraZeneca Related Developments
11.8 SciClone Pharmaceuticals
11.8.1 SciClone Pharmaceuticals Corporation Information
11.8.2 SciClone Pharmaceuticals Description and Business Overview
11.8.3 SciClone Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 SciClone Pharmaceuticals Polypeptide Drug Products Offered
11.8.5 SciClone Pharmaceuticals Related Developments
11.9 Takeda
11.9.1 Takeda Corporation Information
11.9.2 Takeda Description and Business Overview
11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Takeda Polypeptide Drug Products Offered
11.9.5 Takeda Related Developments
11.10 Roche
11.10.1 Roche Corporation Information
11.10.2 Roche Description and Business Overview
11.10.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Roche Polypeptide Drug Products Offered
11.10.5 Roche Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Polypeptide Drug Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Polypeptide Drug Market Estimates and Projections by Region
12.1.1 Global Polypeptide Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Polypeptide Drug Revenue Forecast by Regions 2021-2026
12.2 North America Polypeptide Drug Market Size Forecast (2021-2026)
12.2.1 North America: Polypeptide Drug Sales Forecast (2021-2026)
12.2.2 North America: Polypeptide Drug Revenue Forecast (2021-2026)
12.2.3 North America: Polypeptide Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Polypeptide Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Polypeptide Drug Sales Forecast (2021-2026)
12.3.2 Europe: Polypeptide Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Polypeptide Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Polypeptide Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Polypeptide Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Polypeptide Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Polypeptide Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Polypeptide Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Polypeptide Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Polypeptide Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Polypeptide Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Polypeptide Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Polypeptide Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Polypeptide Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Polypeptide Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Polypeptide Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Polypeptide Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Polypeptide Drug Market Segments
Table 2. Ranking of Global Top Polypeptide Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Polypeptide Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Nasal Administration
Table 6. Major Manufacturers of Lung Administration
Table 7. Major Manufacturers of Oral Administration
Table 8. Major Manufacturers of Transdermal Administration
Table 9. Global Polypeptide Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 10. Global Polypeptide Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 11. Global Polypeptide Drug Sales by Regions 2015-2020 (MT)
Table 12. Global Polypeptide Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Polypeptide Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Polypeptide Drug Sales by Manufacturers (2015-2020) (MT)
Table 15. Global Polypeptide Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Polypeptide Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Polypeptide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypeptide Drug as of 2019)
Table 18. Polypeptide Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Polypeptide Drug Price (2015-2020) (USD/MT)
Table 21. Polypeptide Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Polypeptide Drug Product Type
Table 23. Date of International Manufacturers Enter into Polypeptide Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 26. Global Polypeptide Drug Sales Share by Type (2015-2020)
Table 27. Global Polypeptide Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Polypeptide Drug Revenue Share by Type (2015-2020)
Table 29. Polypeptide Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 31. Global Polypeptide Drug Sales Share by Application (2015-2020)
Table 32. North America Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 33. North America Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 34. North America Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 37. North America Polypeptide Drug Sales Market Share by Type (2015-2020)
Table 38. North America Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 39. North America Polypeptide Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 41. Europe Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 45. Europe Polypeptide Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 47. Europe Polypeptide Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Polypeptide Drug Sales by Region (2015-2020) (MT)
Table 49. Asia Pacific Polypeptide Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Polypeptide Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Polypeptide Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 53. Asia Pacific Polypeptide Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 55. Asia Pacific Polypeptide Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 57. Latin America Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 61. Latin America Polypeptide Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 63. Latin America Polypeptide Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Polypeptide Drug Sales by Country (2015-2020) (MT)
Table 65. Middle East and Africa Polypeptide Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Polypeptide Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Polypeptide Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Polypeptide Drug Sales by Type (2015-2020) (MT)
Table 69. Middle East and Africa Polypeptide Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Polypeptide Drug Sales by Application (2015-2020) (MT)
Table 71. Middle East and Africa Polypeptide Drug Sales Market Share by Application (2015-2020)
Table 72. Novartis Corporation Information
Table 73. Novartis Description and Major Businesses
Table 74. Novartis Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Novartis Product
Table 76. Novartis Recent Development
Table 77. Merck Serono Corporation Information
Table 78. Merck Serono Description and Major Businesses
Table 79. Merck Serono Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Merck Serono Product
Table 81. Merck Serono Recent Development
Table 82. Ferring Pharmaceuticals Corporation Information
Table 83. Ferring Pharmaceuticals Description and Major Businesses
Table 84. Ferring Pharmaceuticals Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Ferring Pharmaceuticals Product
Table 86. Ferring Pharmaceuticals Recent Development
Table 87. Ipsen PHarma Biotech Corporation Information
Table 88. Ipsen PHarma Biotech Description and Major Businesses
Table 89. Ipsen PHarma Biotech Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Ipsen PHarma Biotech Product
Table 91. Ipsen PHarma Biotech Recent Development
Table 92. Lilly Corporation Information
Table 93. Lilly Description and Major Businesses
Table 94. Lilly Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Lilly Product
Table 96. Lilly Recent Development
Table 97. Asahi Kasei Corporation Information
Table 98. Asahi Kasei Description and Major Businesses
Table 99. Asahi Kasei Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Asahi Kasei Product
Table 101. Asahi Kasei Recent Development
Table 102. AstraZeneca Corporation Information
Table 103. AstraZeneca Description and Major Businesses
Table 104. AstraZeneca Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AstraZeneca Product
Table 106. AstraZeneca Recent Development
Table 107. SciClone Pharmaceuticals Corporation Information
Table 108. SciClone Pharmaceuticals Description and Major Businesses
Table 109. SciClone Pharmaceuticals Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. SciClone Pharmaceuticals Product
Table 111. SciClone Pharmaceuticals Recent Development
Table 112. Takeda Corporation Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Takeda Product
Table 116. Takeda Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Major Businesses
Table 119. Roche Polypeptide Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Roche Product
Table 121. Roche Recent Development
Table 122. Sanofi Corporation Information
Table 123. Sanofi Description and Major Businesses
Table 124. Sanofi Polypeptide Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Sanofi Product
Table 126. Sanofi Recent Development
Table 127. Global Polypeptide Drug Sales Forecast by Regions (2021-2026) (MT)
Table 128. Global Polypeptide Drug Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Polypeptide Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Polypeptide Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Polypeptide Drug Sales Forecast by Country (2021-2026) (MT)
Table 132. North America: Polypeptide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Polypeptide Drug Sales Forecast by Country (2021-2026) (MT)
Table 134. Europe: Polypeptide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Polypeptide Drug Sales Forecast by Region (2021-2026) (MT)
Table 136. Asia Pacific: Polypeptide Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Polypeptide Drug Sales Forecast by Country (2021-2026) (MT)
Table 138. Latin America: Polypeptide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Polypeptide Drug Sales Forecast by Country (2021-2026) (MT)
Table 140. Middle East and Africa: Polypeptide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Polypeptide Drug Players
Table 145. Polypeptide Drug Customers List
Table 146. Polypeptide Drug Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Polypeptide Drug Product Picture
Figure 2. Global Polypeptide Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Nasal Administration Product Picture
Figure 5. Lung Administration Product Picture
Figure 6. Oral Administration Product Picture
Figure 7. Transdermal Administration Product Picture
Figure 8. Global Polypeptide Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Immunity Regulating Medicine (Allergy Infection and Immune)
Figure 10. Digestive System Drugs (Gastrointestinal Type)
Figure 11. Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure 12. Gynecologic or Obstetric Drug
Figure 13. Tumor Drug
Figure 14. Urinary System Drug
Figure 15. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure 16. Polypeptide Drug Report Years Considered
Figure 17. Global Polypeptide Drug Market Size 2015-2026 (US$ Million)
Figure 18. Global Polypeptide Drug Sales 2015-2026 (MT)
Figure 19. Global Polypeptide Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Polypeptide Drug Sales Market Share by Region (2015-2020)
Figure 21. Global Polypeptide Drug Sales Market Share by Region in 2019
Figure 22. Global Polypeptide Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global Polypeptide Drug Revenue Market Share by Region in 2019
Figure 24. Global Polypeptide Drug Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Polypeptide Drug Revenue in 2019
Figure 26. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Polypeptide Drug Sales Market Share by Type (2015-2020)
Figure 28. Global Polypeptide Drug Sales Market Share by Type in 2019
Figure 29. Global Polypeptide Drug Revenue Market Share by Type (2015-2020)
Figure 30. Global Polypeptide Drug Revenue Market Share by Type in 2019
Figure 31. Global Polypeptide Drug Market Share by Price Range (2015-2020)
Figure 32. Global Polypeptide Drug Sales Market Share by Application (2015-2020)
Figure 33. Global Polypeptide Drug Sales Market Share by Application in 2019
Figure 34. Global Polypeptide Drug Revenue Market Share by Application (2015-2020)
Figure 35. Global Polypeptide Drug Revenue Market Share by Application in 2019
Figure 36. North America Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 37. North America Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Polypeptide Drug Sales Market Share by Country in 2019
Figure 39. North America Polypeptide Drug Revenue Market Share by Country in 2019
Figure 40. U.S. Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 41. U.S. Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 43. Canada Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Polypeptide Drug Market Share by Type in 2019
Figure 45. North America Polypeptide Drug Market Share by Application in 2019
Figure 46. Europe Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 47. Europe Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Polypeptide Drug Sales Market Share by Country in 2019
Figure 49. Europe Polypeptide Drug Revenue Market Share by Country in 2019
Figure 50. Germany Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 51. Germany Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 53. France Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 55. U.K. Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 57. Italy Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 59. Russia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Polypeptide Drug Market Share by Type in 2019
Figure 61. Europe Polypeptide Drug Market Share by Application in 2019
Figure 62. Asia Pacific Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 63. Asia Pacific Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Polypeptide Drug Sales Market Share by Region in 2019
Figure 65. Asia Pacific Polypeptide Drug Revenue Market Share by Region in 2019
Figure 66. China Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 67. China Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 69. Japan Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 71. South Korea Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 73. India Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 75. Australia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 77. Taiwan Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 79. Indonesia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 81. Thailand Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 83. Malaysia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 85. Philippines Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 87. Vietnam Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Polypeptide Drug Market Share by Type in 2019
Figure 89. Asia Pacific Polypeptide Drug Market Share by Application in 2019
Figure 90. Latin America Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 91. Latin America Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Polypeptide Drug Sales Market Share by Country in 2019
Figure 93. Latin America Polypeptide Drug Revenue Market Share by Country in 2019
Figure 94. Mexico Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 95. Mexico Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 97. Brazil Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 99. Argentina Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Polypeptide Drug Market Share by Type in 2019
Figure 101. Latin America Polypeptide Drug Market Share by Application in 2019
Figure 102. Middle East and Africa Polypeptide Drug Sales Growth Rate 2015-2020 (MT)
Figure 103. Middle East and Africa Polypeptide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Polypeptide Drug Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Polypeptide Drug Revenue Market Share by Country in 2019
Figure 106. Turkey Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 107. Turkey Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 109. Saudi Arabia Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Polypeptide Drug Sales Growth Rate (2015-2020) (MT)
Figure 111. U.A.E Polypeptide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Polypeptide Drug Market Share by Type in 2019
Figure 113. Middle East and Africa Polypeptide Drug Market Share by Application in 2019
Figure 114. North America Polypeptide Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. North America Polypeptide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Polypeptide Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Europe Polypeptide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Polypeptide Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Asia Pacific Polypeptide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Polypeptide Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Latin America Polypeptide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Polypeptide Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Middle East and Africa Polypeptide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
副鼻腔治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 化学合成ポリペプチド薬の世界市場（～2026年） Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly b…
- 膵島アミロイドポリペプチドの世界市場（～2026年） Market Analysis and Insights: Global Islet Amyloid Polypeptide Market The global Islet Amyloid Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Islet Amyloid Polypeptide Scope and Market Size Islet Amyloid P…
- 胃抑制性ポリペプチド受容体の世界市場（～2026年） Market Analysis and Insights: Global Gastric Inhibitory Polypeptide Receptor Market The global Gastric Inhibitory Polypeptide Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastric Inhibitory Polypeptide Rece…
- コラーゲンポリペプチドの世界市場（～2026年） Market Analysis and Insights: Global Collagen Polypeptide Market The global Collagen Polypeptide market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Collagen Polypeptide Scope and Market Size Collagen Polypeptide market is…